Literature DB >> 30887148

The Dutch Bipolar Offspring Study: Cognitive Development and Psychopathology.

Wanda M Tempelaar1,2, Esther Mesman3, Elemi J Breetvelt4,5, Manon H J Hillegers3.   

Abstract

Various aspects of the relationship between cognitive impairment and bipolar disorder are not clear yet. This study examines cognitive and educational functioning prospectively in offspring at familial risk for bipolar disorder, in order to improve our understanding of the association between cognitive functioning and psychopathology. Bipolar offspring (N = 92) from the prospective Dutch bipolar offspring study were evaluated at adolescence and adulthood for IQ estimate, educational achievement and development of any psychiatric disorder. The main outcome was IQ estimate after 12 years of follow-up (offspring mean age 28 years). Generalized estimating equation (GEE) analyses showed that any lifetime DSM-IV axis I diagnosis was related to a lower cognitive outcome at adulthood as compared to unaffected bipolar offspring. No specific association was found for type of diagnosis. Early onset psychopathology (diagnosis at or before age 15 years) was significantly related to lower IQ estimate at adulthood, indicating a sensitive period for neurocognitive development.

Entities:  

Keywords:  Bipolar offspring; Cognitive development; Psychopathology

Year:  2019        PMID: 30887148     DOI: 10.1007/s10802-019-00532-7

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  53 in total

1.  Analytic implications of changing neuropsychological test versions during a longitudinal study because of aging in a pediatric cohort.

Authors:  D Usner; G FitzGerald
Journal:  Control Clin Trials       Date:  1999-10

Review 2.  Review of studies of child and adolescent offspring of bipolar parents.

Authors:  M P DelBello; B Geller
Journal:  Bipolar Disord       Date:  2001-12       Impact factor: 6.744

3.  Prevalence of psychopathology in children of a bipolar parent.

Authors:  M Wals; M H Hillegers; C G Reichart; J Ormel; W A Nolen; F C Verhulst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-09       Impact factor: 8.829

Review 4.  Age at onset in bipolar affective disorders: a review.

Authors:  Marion Leboyer; Chantal Henry; Marie-Laure Paillere-Martinot; Frank Bellivier
Journal:  Bipolar Disord       Date:  2005-04       Impact factor: 6.744

5.  Academic and cognitive abilities in children of parents with bipolar disorder: a test of the nonverbal learning disability model.

Authors:  Patricia McDonough-Ryan; Melissa DelBello; Paula K Shear; Douglas M Ris; Ceasar Soutullo; Stephen M Strakowski
Journal:  J Clin Exp Neuropsychol       Date:  2002-05       Impact factor: 2.475

6.  Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity.

Authors:  C Hollis
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

7.  IQ stabilization in childhood-onset schizophrenia.

Authors:  Peter A Gochman; Deanna Greenstein; Alexandra Sporn; Nitin Gogtay; Barbara Keller; Philip Shaw; Judith L Rapoport
Journal:  Schizophr Res       Date:  2005-09-15       Impact factor: 4.939

8.  Psychopathology in the adolescent offspring of bipolar parents.

Authors:  Catrien G Reichart; Marjolein Wals; Manon H J Hillegers; Johan Ormel; Willem A Nolen; Frank C Verhulst
Journal:  J Affect Disord       Date:  2004-01       Impact factor: 4.839

9.  Impact of stressful life events, familial loading and their interaction on the onset of mood disorders: study in a high-risk cohort of adolescent offspring of parents with bipolar disorder.

Authors:  Manon H J Hillegers; Huibert Burger; Marjolein Wals; Catrien G Reichart; Frank C Verhulst; Willem A Nolen; Johan Ormel
Journal:  Br J Psychiatry       Date:  2004-08       Impact factor: 9.319

10.  Early age at onset as a risk factor for poor outcome of bipolar disorder.

Authors:  Tasha D Cate Carter; Emanuela Mundo; Sagar V Parikh; James L Kennedy
Journal:  J Psychiatr Res       Date:  2003 Jul-Aug       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.